أعرض في EDS

Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies.

التفاصيل البيبلوغرافية
العنوان: Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies.
المؤلفون: Wei, Fen, Jia, Xiu-Jie, Yu, Su-Qin, Gu, Ye, Wang, Li, Guo, Xiao-Mei, Wang, Min, Zhu, Feng, Cheng, Xiang, Wei, Yu-Miao, Zhou, Zi-Hua, Fu, Michael, 1963, Liao, Yu-Hua
المصدر: Heart. 97(6):479-84
مصطلحات موضوعية: Dermatology and Venereal Diseases, Dermatologi och venereologi, Microbiology in the medical area, Mikrobiologi inom det medicinska området, Adult, Aged, Angiotensin II Type 1 Receptor Blockers, therapeutic use, Antihypertensive Agents, adverse effects, Autoantibodies, blood, Benzimidazoles, Blood Pressure, drug effects, Double-Blind Method, Female, Humans, Hypertension, drug therapy, immunology, physiopathology, Imidazolidines, Male, Middle Aged, Receptor, Angiotensin, Type 1, Tetrazoles, Treatment Outcome
الوصف: Anti-angiotensin II receptor subtype 1 (AT1 receptor) autoantibodies have previously been shown in sera of hypertensive patients. This study assessed whether anti-AT1-receptor autoantibody in serum is correlated with the efficacy of an AT1-receptor blocker (ARB; candesartan)-based regimen in hypertensive patients after 8 weeks of treatment.
الوصول الحر: https://gup.ub.gu.se/publication/150961Test
قاعدة البيانات: SwePub
الوصف
تدمد:1468201X
DOI:10.1136/hrt.2009.192104